SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has reported continued growth in the adoption of its SSi Mantra surgical robotic system, according to a company update issued September 10. As of September 8, 2026, 238 SSi Mantra systems were installed globally, a 42% increase from 168 at the end of 2025. The installed base now spans 12 countries, following recent launches in Colombia and Sri Lanka and further international expansion. Cumulative procedures performed with the system reached 14,103, representing a 79% increase from 7,885 at the end of 2025. Approximately 1,500 physicians have been trained on the SSi Mantra platform.
The company also highlighted advancements in pediatric applications, including a robotic kidney procedure performed on a 45-day-old infant in India using 5-millimeter instruments. This milestone demonstrates the system's precision and versatility in treating extremely young patients, a segment where minimally invasive options are limited. Additionally, SS Innovations reported 188 cumulative robotic telesurgeries as of August 31, alongside long-distance procedures connecting surgeons and patients across countries. These telesurgeries underscore the potential for remote surgical care, which could improve access to specialized expertise in underserved regions.
From a regulatory perspective, SS Innovations expects FDA review of its 510(k) submission by the end of Q1 2027 and believes EU CE marking for SSi Mantra could be obtained by the end of 2026. These milestones, if achieved, would open major markets and further accelerate global adoption. The company's progress reflects a broader trend in healthcare toward robotic-assisted surgery, which offers benefits such as smaller incisions, reduced pain, and faster recovery times.
For the Long Beach and surrounding Los Angeles area, SS Innovations' growth story is part of a larger ecosystem of medical technology innovation. While the company is not headquartered in Long Beach, its advancements contribute to the region's reputation as a hub for healthcare and technology development. The increase in procedures and installations signals growing acceptance of surgical robotics, which could lead to improved patient outcomes and more efficient healthcare delivery. As SS Innovations continues to expand, it may also spur local investment and collaboration in the medical device sector.
The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. For full terms of use and disclaimers, see https://IBN.ai/Disclaimer.
This article includes forward-looking statements that involve risks and uncertainties. Actual results may differ materially. Undue reliance should not be placed on these statements.
